AXICABTAGENE CILOLEUCEL VERSUS TISAGENLECLEUCEL CAR-T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Nico Gagelmann, 385846
INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER'S TRANSFORMATION
EHA Library, Julio Delgado, 385847
THREE YEARS OUTCOMES OF PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS FOLLOWING ANTI CD19 CAR-T CELL THERAPY - A SINGLE CENTER EXPERIENCE
EHA Library, Mika Geva, 385848
IDENTIFICATION OF BIOMARKERS AND RISK FACTORS FOR IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME (ICANS) IN CD19-DIRECTED CAR T-CELL THERAPY: A RETROSPECTIVE MACHINE LEARNING-BASED ANALYSIS.
EHA Library, Marina Gómez-Llobell, 385849
INFUSION OF 14 DAYS BLINATUNOMAB IN COMBINATION WITH CHEMOTHERAPY FOR 46-DAY MRD+ PEDIATRIC B-ALL PATIENTS IN INTERMEDIATE/HIGH-RISK GROUP RESULTS IN MRD CONVERSION.
EHA Library, Changwen Xue, 385850
SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT
EHA Library, Jaap Jan Boelens, 385851
IL-10 PLUS THE EASIX SCORE PREDICT BLEEDING EVENTS AFTER ANTI-CD19 CAR T-CELL THERAPY
EHA Library, Heng Mei, 385852
IN-DEPTH GENOME INTEGRITY EVALUATION AND GMP-COMPLIANT MANUFACTURING OF HDR GENE EDITED CD4+ T CELLS FOR THE TREATMENT OF HYPER IGM 1
EHA Library, Daniele Canarutto, 385853
SAFETY AND EFFICACY OF IBI346, A FIRST-IN-CLASS BCMA-TARGETING MODULAR CAR-T CELL THERAPY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PRELIMINARY RESULTS FROM TWO PHASE I STUDIES
EHA Library, Chengcheng Fu, 385854
REMOTE MONITORING OF CAR T-CELL TREATED PATIENTS BY A SPECIALIZED NURSE TO DETECT AND MANAGE LATE COMPLICATIONS: REPORT OF THE CARAMA PROGRAM
EHA Library, Fanny Colin, 385855
UPDATED RESULTS OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) CD22+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
EHA Library, Nicolas Boissel, 385856
PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY
EHA Library, Anil Kamat, 385857
EFFICACY OBSERVATION OF A SECOND INFUSION OF BCMA-CAR-T CELLS IN PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA
EHA Library, Yi Wang, 385858
FIRST EVALUATION OF A MOBILE HEALTH APP DEVELOPED TO MONITOR ACUTE TOXICITIES AFTER CAR T-CELL THERAPY: A THINK ALOUD STUDY WITH PATIENT EXPERTS
EHA Library, Milan Kos, 385859
CLINICIAN LED NUTRITIONAL ASSESSMENT AND PRE-OPTIMISATION OF PATIENTS UNDERGOING CAR-T CELL THERAPY
EHA Library, Frances Seymour, 385860
DOES TOCILIZUMAB INCREASE THE RISK OF INFECTIONS IN PATIENTS UNDERGOING CAR-T THERAPY?
EHA Library, Mona Asslan, 385861
CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY
EHA Library, Shota Yokoyama, 385862
CELLULAR DYNAMICS IN RESPONDERS AND NON-RESPONDERS AFTER THE TREATMENT OF PATIENTS WITH AGGRESSIVE B-ZELL LYMPHOMAS WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS
EHA Library, Vladan VUCINIC, 385863
THE CLINICAL SPECTRUM AND PROGNOSTIC FACTORS OF ERDHEIM-CHESTER DISEASE
EHA Library, Jia-Wen Dai, 385864
BASELINE CALCIUM WAS ASSOCIATED WITH PROGNOSIS AFTER CAR T-CELL THERAPY
EHA Library, Heng Mei, 385865
DETERMINANTS OF HAEMOGLOBIN IN SICKLE CELL DISEASE PATIENTS IN SUB-SAHARAN AFRICA: MAJOR IMPACT OF THE NATIVE COUNTRY AND INDEPENDENT EFFECTS OF INFLAMMATION AND HAEMOLYSIS.
EHA Library, Marica Rossi, 385866
A SINGLE CENTRE PERSPECTIVE ON PREGNANCY OUTCOMES AND SICKLE CELL COMPLICATIONS IN WOMEN ON HYDROXYCARBAMIDE PERI-CONCEPTION.
EHA Library, Maria Gregori, 385867
COMPARATIVE STUDY OF CYCLOSPORINE VERSUS TACROLIMUS IN ADDITION TO METHOTREXATE AS GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING ALLOGENEIC STEM CELL TRANSPLANTATION OF SICKLE CELL DISEASE
EHA Library, Mostafa Mohammed Saleh, 385868
THE EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION ON CEREBRAL PERFUSION AND OXYGEN METABOLISM IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Liza Afzali-Hashemi, 385869
PREVALENCE AND RISK FACTORS FOR RETINOPATHY IN SICKLE CELL DISEASE
EHA Library, Kate Gardner, 385870
GENOTYPE GUIDED DISEASE MANAGEMENT IN HBSC SICKLE CELL DISEASE USING PHLEBOTOMY: IMPACT ON SYMPTOMS AND DISEASE PARAMETERS
EHA Library, Anne-Marie Asemissen, 385871
ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
EHA Library, Myrthe van Dijk, 385872
SYSTEMATIC INVESTIGATION OF HYDROXYUREA TREATMENT EFFECT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Varsha Bhat, 385873
RARE ANAEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP): DISTRIBUTION OF PATIENTS AFFECTED BY RADS IN EUROPE
EHA Library, Maria Del Mar Mañú Pereira, 385875
PREDICTORS OF VOC RATE DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH HBSS IN A NEWBORN COHORT STUDY
EHA Library, Muriel Ramalli, 385876
IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM
EHA Library, Chiara Federici, 385877
EPIDEMIOLOGY AND TREATMENT OF SICKLE CELL DISEASE ASSOCIATED VASO-OCCLUSIVE CRISES IN INPATIENT AND EMERGENCY CARE SETTINGS:  A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
EHA Library, Ami Patel, 385878
ACCURATE CELL-FREE HEME DOSAGE IN PLASMA CORRELATES WITH ANEMIA, HEMOLYSIS AND SICKLE CELL NEPHROPATHY SEVERITY
EHA Library, Laura Bencheikh, 385879
PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Biree Andemariam, 385880
POSITRON EMISSION TOMOGRAPHY IMAGING OF VLA-4 AS A NEW BIOMARKER OF VASO-OCCLUSION IN SICKLE CELL DISEASE
EHA Library, Enrico Novelli, 385881
THE RELATIONSHIP BETWEEN MEDICATION ADHERENCE, BARRIERS TO MEDICATION ADHERENCE, AND QUALITY OF LIFE IN SICKLE CELL DISEASE
EHA Library, Kathryn King, 385882
OUTCOMES OF COVID-19 INFECTION IN INDIVIDUALS WITH SICKLE CELL DISEASE OR SICKLE CELL TRAIT: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Stéphanie Forté, 385883
AGEING IMPACTS HYDROXYCARBAMIDE DOSING IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Isabelle Doss, 385884
ASSESSING THE ROLE OF MICRORNAS IN HYDROXYUREA -MEDIATED HBF INDUCTION IN HAEMOGLOBINOPATHIES PATIENTS
EHA Library, Neha Kargutkar, 385885
L-GLUTAMINE: A NOVEL AND EFFECTIVE THERAPEUTIC TOOL FOR VOC REDUCTION IN SCD
EHA Library, Pablo Bartolucci, 385886
EPELEUTON, A NOVEL SYNTHETIC Ω-3 FATTY ACID, REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS UNDER PHYSIOLOGICAL FLOW CONDITIONS
EHA Library, Moayed Hamza, 385887
ASSESSING ADHERENCE TO EMERGENCY DEPARTMENT PROTOCOLS FOR SICKLE CELL DISEASE: IMPLICATIONS FOR QUALITY OF CARE
EHA Library, Charlotte van Tuijn, 385888
REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
EHA Library, Kim Summers, 385889
PRACTICE-BASED EVIDENCE: LONG-TERM SAFETY COHORT OF DEFERIPRONE IN PATIENTS WITH SICKLE CELL DISEASE FROM THE US REGISTRY
EHA Library, Sherif Badawy, 385890
INTRAVENOUS FLUID REPLACEMENT THERAPY AND HOSPITAL OUTCOMES FOR VASO-OCCLUSIVE EPISODES IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Abraham Haimed, 385891
AVASCULAR NECROSIS IN PATIENTS WITH SICKLE CELL DISEASE: A RETROSPECTIVE ANALYSIS AT A SPECIALIST HAEMOGLOBINOPATHY CENTRE
EHA Library, Niamh Loughran, 385892
THE IMPACT OF ILLNESS PERCEPTION AND STIGMA ON PATIENT-REPORTED OUTCOMES IN SICKLE CELL DISEASE
EHA Library, Savannah Winkler, 385893
HYDROXYUREA AND LIMB ULCERS: IS IT WORTH SUSPENDING? RETROSPECTIVE COHORT STUDY OF BRAZILIAN ADULT PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Bruno D Benites, 385894
MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN ITALY
EHA Library, Chuka Udeze, 385895
CHARACTERISATION OF QUALITY OF LIFE-LINKED PATIENT-REPORTED OUTCOMES THROUGH A DIGITAL AND CONTINUOUS REMOTE MONITORING ECOSYSTEM IN SICKLE CELL DISEASE.
EHA Library, Kim Summers, 385896
SAFETY PROFILE OF KETOROLAC CONTINUOUS INFUSION IN SICKLE CELL RELATED ACUTE VASO-OCCLUSIVE CRISIS
EHA Library, Valeria Maria Pinto, 385897
VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES
EHA Library, Kadère Konté, 385898
PUBERTAL DEVELOPMENT OF TRANSFUSION DEPENDENT THALASSEMIA PATIENTS AT THE ERA OF ORAL CHELATION WITH DEFERASIROX : RESULTS OF THE FRENCH NATIONAL REGISTRY NATHALY
EHA Library, isabelle Thuret, 385899
MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN ITALY
EHA Library, Chuka Udeze, 385900
ORTHOTOPIC LIVER TRANSPLANT IN SICILIAN HEMOGLOBINOPHATIES PATIENTS
EHA Library, Rita Barone, 385901
CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
EHA Library, Antonella Meloni, 385902
THROMBOEMBOLIC EVENTS  IN SPLENECTOMISED VERSUS NON-SPLENECTOMISED THALASSEMIA PATIENTS: A META-ANALYSIS OF OBSERVATIONAL STUDIES
EHA Library, Tsampika Vasileia Kalamara, 385903
MULTIPARAMETRIC CMR AND CARDIAC COMPLICATIONS IN THALASSEMIA INTERMEDIA
EHA Library, Antonella Meloni, 385904
MOTION ABNORMALITIES IN THE LEFT VENTRICLE OF THALASSEMIA INTERMEDIA PATIENTS
EHA Library, Antonella Meloni, 385905
MITAPIVAT AMELIORATES IN VITRO HUMAN Β THALASSEMIC ERYTHROID MATURATION INDEX AND MODULATES THE EXPRESSION OF THE CYTOPROTECTOR PEROXIREDOXIN-2.
EHA Library, Lucia de Franceschi, 385906
CHRONIC HEPATITIS C VIRUS INFECTION IS ASSOCIATED WITH AN INCREASED RISK OF  CARDIAC COMPLICATIONS IN THALASSEMIA MAJOR
EHA Library, Antonella Meloni, 385907
INDUCTION OF FETAL HEMOGLOBIN BY TARGETED DELETION OF ZINC FINGER DOMAIN WITHIN BCL11A GENE USING CRISPR-CAS9 TECHNOLOGY
EHA Library, Afsar Ali Mian, 385908
INFLAMMATORY AND SENESCENCE-ASSOCIATED MEDIATORS AFFECT THE PERSISTENCE OF HUMORAL RESPONSE TO COVID-19 MRNA VACCINATION IN TRANSFUSION-DEPENDENT BETA-THALASSEMIC PATIENTS
EHA Library, Chiara Agrati, 385909
NEUROCOGNITIVE FUNCTION AND PSYCHOLOGICAL ASSESSMENT IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA PATIENTS: RELATION TO BRAIN IRON CONTENT
EHA Library, Amira Adly, 385910
HEALTHCARE RESOURCE USE, ECONOMIC BURDEN AND IN-PATIENT MORTALITY IN PATIENTS WITH ALPHA- AND BETA-THALASSEMIA COMPARED TO MATCHED CONTROLS IN THE REAL-WORLD SETTING
EHA Library, Louise Lombard, 385911
CLINICAL COMPLICATIONS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN GERMANY
EHA Library, Chuka Udeze, 385912
SAFETY AND EFFICACY OF APOTRANSFERRIN INFUSION IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA, THE AIM STUDY
EHA Library, Kadère Konté, 385913
EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
EHA Library, Thomas D. Coates, 385914
THE EMPLOYMENT OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY Β-THALASSEMIA: A MULTICENTER ANALYSIS FROM THE EXTENSION-MYOCARDIAL IRON OVERLOAD IN THALASSEMIA NETWORK (E-MIOT)
EHA Library, Simona Raso, 385915
PIEZO1 GAIN-OF-FUNCTION VARIANTS ACCOUNT FOR STRESSED ERYTHROPOIESIS BY ALTERING APOPTOSIS, HYPOXIA CELL RESPONSE, AND GLYCOLYSIS
EHA Library, Barbara Eleni Rosato, 385916
INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA STUDY
EHA Library, Alexander Röth, 385917
IDENTIFICATION OF THE PRO20THR NOVEL VARIANT IN CDIN1 GENE ALLOWED EXPLORING THE BIOLOGICAL PROCESSES IMPAIRED IN CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I
EHA Library, Roberta Marra, 385918
SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY
EHA Library, Alexander Röth, 385919
COINHERITANCE OF PIEZO1 VARIANTS AND MULTI-LOCUS RED BLOOD CELL DEFECTS ACCOUNT FOR THE SYMPTOMATIC PHENOTYPE IN BETA-THALASSEMIA CARRIERS.
EHA Library, Valeria Maria Pinto, 385920
CLINICALLY RELEVANT HEMOGLOBIN RESPONSE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT – A SUB-ANALYSIS OF THE ACTIVATE TRIAL
EHA Library, Hanny Al-Samkari, 385921
HEMOLYTIC MARKERS, MORTALITY, AND THROMBOEMBOLIC EVENTS IN CAD: RISK ASSESSMENT BY TIME PERIOD SINCE DIAGNOSIS
EHA Library, Quentin A Hill, 385922
MUTATIONS IN THE GAP DOMAIN OF RACGAP1 CAUSE DEVELOPMENTAL AND ERYTHROID DEFECTS IN ZEBRAFISH
EHA Library, Lídia Romero-Cortadellas, 385923
THE CLINICAL CHARACTERISTICS AND OVERALL SURVIVAL OF PATIENTS WITH PYRUVATE KINASE DEFICIENCY IN THE UK: A REAL-WORLD STUDY
EHA Library, Sara Higa, 385924
MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL
EHA Library, Rachael F. Grace, 385925
DRUGS ASSOCIATED PORPHYRIA:A PHARMACOVIGILANCE STUDY
EHA Library, qi wang, 385926
COMORBIDITIES AND COMPLICATIONS IN ADULTS WITH PYRUVATE KINASE DEFICIENCY ACCORDING TO HEMOGLOBIN STRATA – A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY
EHA Library, Dagmar Pospíŝilová, 385927
CLINICAL AND GENETIC STUDY OF HEREDITARY SPHEROCYTOSIS IN THE SPANISH POPULATION.
EHA Library, Lucia Castilla, 385928
SYSTEMATICALLY REDUCED RED CELL PHOSPHATIDYLSERINE FLIPPASE ACTIVITY IS SUFFICIENT TO INDUCE HEREDITARY HEMOLYTIC ANEMIA
EHA Library, Myrthe van Dijk, 385929
RECOMBINANT ERYTHROPOIETIN IN AUTOIMMUNE HEMOLYTIC ANEMIA WITH INADEQUATE RETICULOCYTOSIS: A SINGLE CENTER PROSPECTIVE STUDY
EHA Library, Giacinto Luca Pedone, 385930
LONG-TERM IMPACT OF OLIPUDASE ALFA ENZYME REPLACEMENT THERAPY ON SPLEEN VOLUME AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN AND ADULTS WITH CHRONIC ACID SPHINGOMYELINASE DEFICIENCY
EHA Library, Jesus Villarrubia, 385931
THE DANISH SCREENING PROGRAM FOR HEMOGLOBINOPATHIES: A 16-YEAR REVIEW
EHA Library, Esther Gravholt, 385932
PKM AND PKR EXPRESSION DURING HEMATOPOIESIS AND ERYTHROPOIESIS
EHA Library, Erin Tsai, 385933
SERUM BIOMARKERS AS PREDICTORS OF RESPONSE TO SUTIMLIMAB IN COLD AGGLUTININ DISEASE (CAD): A POST-HOC ANALYSIS OF PHASE 3 CARDINAL AND CADENZA STUDY DATA
EHA Library, Wilma Barcellini, 385934
CONCOMITANT USE OF SUTIMLIMAB AND COVID-19 VACCINES IN PATIENTS WITH COLD AGGLUTININ DISEASE FROM THE PHASE 3 CARDINAL AND CADENZA STUDIES
EHA Library, Bruno Fattizzo, 385935
COMBINING ALK2 INHIBITION WITH A MODIFIED ACTIVIN RECEPTOR IIA LIGAND TRAP PROVIDED ADDITIVE BENEFITS IN RESOLVING ANEMIA IN A MOUSE MODEL OF ANEMIA OF INFLAMMATION
EHA Library, Emiliano Melgar-Bermudez, 385936
HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY AND IMPROVES IMMUNE ANTITUMOR FUNCTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Jessica Bordini, 385937
ROLE OF HEMOLYSIS AND ITS EFFECTS ON IRON DISTRIBUTION AND IMMUNE CELL POLARIZATION LINKED TO ORGAN INJURY
EHA Library, Christina Mertens, 385938
THE DYNAMIC INTERACTION BETWEEN INFLAMMATION AND THE IRON SENSOR HFE, IN SEVERE MALARIA-INDUCED ANEMIA
EHA Library, Ana Pêgo, 385939
A NEW POTENTIAL AND PREVALENT SIDE EFFECT OF FERRIC CARBOXYMALTOSE: METHEMOGLOBINEMIA. A CASE-CONTROL STUDY.
EHA Library, Muhammet Özbilen, 385940
DIAGNOSTIC ACCURACY OF AN AUTOMATED MAGNETIC RESONANCE IMAGE ANALYSIS SYSTEM FOR THE RAPID EVALUATION OF LIVER IRON CONCENTRATION IN PATIENTS WITH HFE RELATED HEMOCHROMATOSIS.
EHA Library, Tim St Pierre, 385941
EFFECT OF IRON DEFICIENCY ANEMIA ON PROPRIOCEPTION IN ADULT WOMEN
EHA Library, Ines Mezghani, 385942
A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
EHA Library, Harikrishnan P, 385943
TRANSFERRIN NON-CODING VARIANTS CAUSE MRNA DESTABILISATION IN CONGENITAL HYPOTRANSFERRINEMIA
EHA Library, Xenia Ferrer, 385944
MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
EHA Library, Eduard J. van Beers, 385945
INITIAL DATA FROM THE BEACON TRIAL: A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
EHA Library, Gayle Ross, 385946

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings